title: What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
authors.affiliation: Division of Transplantation, Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA. kim.olthoff@uphs.upenn.edu
authors.forename: Kim M
authors.initials: KM
authors.lastname: Olthoff
authors.forename: Alejandro
authors.initials: A
authors.lastname: Forner
authors.forename: Stefan
authors.initials: S
authors.lastname: Hübscher
authors.forename: John
authors.initials: J
authors.lastname: Fung
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D003661:Decision Support Techniques; D019317:Evidence-Based Medicine; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation; D009367:Neoplasm Staging / Q000379:methods*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011379:Prognosis